SBIR Phase 1 vs Phase 2: Funding, Timeline, and How to Move Up (2026)

If you are new to SBIR, the three-phase structure is the first thing you have to wrap your head around. Most first-time founders focus on Phase 1, get the award, and then realize they don't actually understand how Phase 2 works, or worse, miss that Phase 3 (the commercialization phase) is where the real money is.

This guide breaks down SBIR Phase 1 vs Phase 2 end-to-end: funding, duration, who can apply, success rates, and how to move from one to the next. If you are still figuring out what SBIR is in the first place, start with our pillar on what SBIR is and come back here.

Quick Answer: SBIR Phase 1 vs Phase 2

SBIR Phase 1 funds feasibility studies (up to ~$323,090, 6–12 months) and is the entry point for most applicants. SBIR Phase 2 funds full prototype development (up to ~$2,153,927, 24 months) and is generally reserved for successful Phase 1 awardees, with the exception of Direct-to-Phase-II tracks at DoD and NIH. Phase 3 is commercialization — it carries no SBIR funding cap, no competition requirement, and is the bridge to sole-source federal contracts. Phase 1 win rates run 15–25% across major agencies; Phase 2 conversion from a successful Phase 1 runs 40–55%.

The Three SBIR Phases at a Glance

The dollar caps shown above are the SBA-published statutory caps as of 2026. Some agencies award higher amounts under specific topics with an SBA waiver. Phase 1 award sizes vary widely by agency. DoD's "Phase I-Open" track sometimes runs as low as $50,000 to $75,000, while NSF Phase 1 typically lands at ~$305,000.

SBIR Phase 1: Feasibility

Purpose: Demonstrate that the proposed innovation is technically feasible and that the small business has the team to do the work. Phase 1 is not a full development project, it's a proof-of-concept study that gives the agency confidence to fund a much larger Phase 2.

Funding (2026): The statutory cap is ~$323,090 including any contract modifications. In practice, awards vary by agency:

• NSF SBIR Phase 1: ~$305,000 across all topics
• DoD SBIR Phase 1: typically $250,000–$295,000; some "Phase I-Open" awards as low as $50,000–$75,000
• NIH SBIR Phase 1: typically up to ~$306,000–$323,000; can be higher with waiver
• NASA, DOE, DHS, USDA SBIR Phase 1: typically $150,000–$295,000

Duration: 6 to 12 months at most agencies. NIH is the outlier. Phase 1 grants can run up to 2 years.

Deliverables: A technical report demonstrating feasibility (laboratory data, computational results, proof of concept), a commercialization plan, and a Phase 2 application roadmap. The technical bar is intentionally low; the commercial bar is intentionally high.

Eligibility: Standard SBIR eligibility applies, for-profit, ≤500 employees, ≥51% U.S. owned, work performed in the U.S., PI primarily employed by the small business. See our SBIR eligibility requirements guide for the full checklist.

Success rates: Phase 1 acceptance rates run 15–25% across DoD, NIH, and NSF. Smaller-pool agencies (EPA, ED, DOT) sometimes run higher rates because the applicant base is smaller, but the topic match has to be near-perfect.

Common Phase 1 mistakes:

• Writing a research paper instead of a proposal, evaluators score on technical merit, commercial potential, and qualifications, not on novelty alone
• Skipping the commercialization plan or treating it as filler
• Misreading the topic, agencies write topics narrowly and proposals that wander off-topic get rejected
• Not lining up the Phase 2 vision in the Phase 1 application. Phase 2 reviewers care about continuity

SBIR Phase 2: Development

Purpose: Build the actual prototype. Phase 2 is where the technology moves from "we showed feasibility" to "we have a working demonstrable system." Phase 2 awardees are expected to have a near-deployable prototype at the end of the period of performance.

Funding (2026): The statutory cap is ~$2,153,927 including modifications. Most Phase 2 awards land at or near the cap.

• NSF SBIR Phase 2: up to ~$1,000,000 (NSF's internal cap, lower than the statutory ceiling)
• DoD SBIR Phase 2: typically $1.5M–$2M; some topics go higher with waiver
• NIH SBIR Phase 2: up to ~$2,153,927; some "Niche Assessment" supplements available
• NASA, DOE Phase 2: typically $1.0M–$1.8M

Duration: 24 months at most agencies. NIH allows up to 3 years.

Eligibility: Only successful Phase 1 awardees can apply at most agencies. The exceptions are Direct-to-Phase-II solicitations at DoD and NIH (covered below). Same general SBIR eligibility rules apply, plus a few continuity requirements: typically, the Phase 2 application has to be submitted within a defined window after Phase 1 ends (often 12 months).

Deliverables: A functional prototype, demonstration data, an updated commercialization plan with named pilot customers, and a Phase 3 transition plan. By Phase 2, the commercialization narrative is no longer a pitch, it's a contract sales plan.

Success rates: Phase 2 conversion runs 40–55% of Phase 1 awardees who apply. Many Phase 1 awardees never apply for Phase 2, either because the technology didn't pan out or because the team didn't build a strong commercial story.

SBIR Phase 3: Commercialization

Phase 3 is the part most first-time SBIR applicants don't understand, and it is by far the most valuable.

Purpose: Move the technology into a paying customer's hands, federal, state, or commercial.

Funding: There is no SBIR funding for Phase 3. Phase 3 work is funded by any source other than the SBIR program: a federal contract, a state contract, private capital, a production order. The small business has to bring the customer.

The unique part: Under 15 U.S.C. § 638(r)(4) and FAR 6.302-5, any federal agency can award a sole-source contract to a company that has successfully completed Phase 1 and Phase 2 work, with no competition required and no sole-source justification needed. Phase 3 contracts:

• Have no dollar cap
• Can be any contract type (FFP, cost-plus, IDIQ, BPA task order)
• Can be awarded by any federal agency, not just the one that funded Phase 1 or Phase 2
• Are statutorily authorized, the contracting officer doesn't have to write a justification for absence of competition

In practice, that means a Phase 2 awardee with a working prototype can negotiate a multi-million-dollar production contract directly, without going through a competitive solicitation. Phase 3 awards over $100M are not uncommon in defense and space.

This is the single biggest reason SBIR is worth pursuing for any company with a federal customer in mind. A successful Phase 1 → Phase 2 → Phase 3 arc is one of the few clean paths from seed-stage R&D to a federal production contract without surrendering equity.

Direct-to-Phase-II: Skipping Phase 1

Direct-to-Phase-II (D2P2) is exactly what it sounds like: an SBIR Phase 2 application without a prior Phase 1 award.

Which agencies offer it:

• DoD. Most service branches and defense agencies offer D2P2 solicitations. Especially common at AFWERX (Air Force) and Army.
• NIH. Runs D2P2 across most institutes, particularly NCI and NIAID.

Eligibility: The applicant must demonstrate that Phase 1-equivalent feasibility has already been achieved, typically through prior internally funded research, prior non-SBIR federal funding, or prior commercial work. Documentation requirements are high, agencies want to see lab data, prototypes, or third-party validation.

Why use D2P2:

• Speed. A traditional Phase 1 → Phase 2 cycle takes 24–36 months end-to-end. D2P2 cuts that in half.
• Capital efficiency. A company that has already done feasibility work shouldn't have to repeat it just to access Phase 2 dollars.
• Strategic fit. Some technologies are too mature for Phase 1 but not yet at production scale. D2P2 fits exactly.

Why D2P2 is harder:

• Higher technical bar in the application, you have to prove feasibility that Phase 1 awardees got months to demonstrate
• More documentation required, prior data, third-party reports, validation evidence
• Lower acceptance rates than traditional Phase 2 in some agencies, because the applicant pool is more competitive

How to Move from Phase 1 to Phase 2

The transition from Phase 1 to Phase 2 is its own discipline. Companies that plan for Phase 2 during Phase 1 convert at much higher rates than companies that treat Phase 1 as a standalone project.

1. Start the Phase 2 proposal during Phase 1. Most agencies allow Phase 2 submissions to overlap with Phase 1 closeout. Don't wait for Phase 1 to finish before starting the Phase 2 narrative.

2. Generate Phase-2-grade data during Phase 1. Phase 2 reviewers want to see specific, quantitative results from Phase 1, not just "we demonstrated feasibility." Build the Phase 1 work plan around the data you'll need to cite in Phase 2.

3. Line up commercialization partners. A Phase 2 commercialization plan with named pilot customers, signed letters of intent, or active matchmaking conversations dramatically outperforms a generic "we'll sell to the government" plan.

4. Watch the timing window. Most agencies require Phase 2 submission within 12 months of Phase 1 end-of-period-of-performance. Missing that window means restarting from Phase 1, a multi-year setback.

5. Address Phase 1 reviewer comments. Phase 2 reviewers often see Phase 1 review comments. If Phase 1 reviewers flagged a concern, address it explicitly in the Phase 2 application.

Common Phase 2 rejection reasons:

• Weak commercialization plan ("we'll sell to the government" with no specifics)
• Phase 1 results that don't match what was promised in the Phase 1 application
• Insufficient prototype maturity at the proposal stage
• Team changes (PI departure, lost key personnel)
• Funding gap between Phase 1 and Phase 2, agencies notice if the company is desperate for cash

Common Misconceptions

"Phase 3 gives you SBIR money." No. Phase 3 has zero SBIR funding. Phase 3 is any work funded by non-SBIR sources that derives from Phase 1 or Phase 2. The value of Phase 3 is the statutory sole-source authority, not a check from the SBIR program.

"You have to do Phase 1 first." Mostly yes, but Direct-to-Phase-II at DoD and NIH lets qualifying companies skip Phase 1 entirely. If you have prior feasibility work, D2P2 is real.

"Phase 2 is automatic if you win Phase 1." No. Phase 2 is a separate competition. Roughly half of Phase 1 awardees who apply for Phase 2 actually win it, and many never apply at all.

"Phase 1 is cheap, so it's worth chasing every topic." No. A mediocre Phase 1 against five topics loses five times. A strong Phase 1 against one well-matched topic is the path that works.

"Phase 3 sole-source is easy because there's no competition." The lack of competition is real, but the federal customer still has to want to buy. Phase 3 success depends on having a federal program office that has been tracking your work since Phase 1 and is actively budgeting to procure your solution.

SBIR Phase 1 vs Phase 2 FAQs

Can I apply for SBIR Phase 2 without doing Phase 1 at the same agency?

In some cases, yes. Phase 2 applications must follow a successful Phase 1, but the Phase 1 doesn't always need to be at the same agency. Specific rules vary; consult the agency's solicitation. Direct-to-Phase-II at DoD and NIH lets you skip Phase 1 entirely if you can prove prior feasibility.

How much does an SBIR Phase 1 typically pay?

The 2026 statutory cap is ~$323,090. Most agencies award $150,000–$300,000 for a standard Phase 1. DoD's "Phase I-Open" track is sometimes as low as $50,000–$75,000 for a quick feasibility scope. NSF Phase 1 is typically ~$305,000 across all topics.

How long does it take to win a Phase 1 award?

From submission to award decision, 3 to 6 months. Add another 1 to 3 months for negotiation and contract or grant execution. Plan for 6 to 9 months from submission to first dollar.

What's the difference between an SBIR grant and an SBIR contract in Phase 1?

The dollar amount is the same. The difference is the funding instrument: NIH, NSF, USDA, and some DOE awards are grants (cost-reimbursable, fewer reporting hooks); DoD, NASA, DHS, and most others are contracts (typically fixed-price, more reporting). Both count equally as Phase 1 awards for purposes of advancing to Phase 2.

Can I do multiple Phase 2 awards on the same project?

Generally no, one Phase 2 per Phase 1 award. However, some agencies offer Phase 2 sequential or Phase 2B supplements that extend the original Phase 2 with additional funding for specific commercialization milestones. NIH and DoD are the most active here.

Does winning Phase 1 increase my odds of winning Phase 2?

Yes, substantially. Phase 2 is restricted to Phase 1 awardees at most agencies, so the applicant pool is much smaller. Phase 2 win rates among Phase 1 awardees who apply run 40–55%, compared to the 15–25% Phase 1 rate.

What if my Phase 2 proposal gets rejected?

You can revise and resubmit at the next deadline (assuming the topic is still open and your timing window is intact), or pursue the work as Phase 3 with non-SBIR funding. Some companies rejected at Phase 2 successfully run a Phase 3 sole-source contract directly with a federal customer who tracked their Phase 1.

Should I prioritize Phase 1 dollars or Phase 2 dollars in my strategy?

Phase 2. Phase 1 is an entry credential; Phase 2 is the real R&D budget; Phase 3 is the federal contract. Plan your Phase 1 backwards from a Phase 2 opportunity, and plan your Phase 2 backwards from a Phase 3 customer. That's how the most successful SBIR companies operate.

Bottom Line

SBIR Phase 1 and Phase 2 are not just sequential checkboxes; they are different products with different goals. Phase 1 is a $300K feasibility credential; Phase 2 is a $2M development project; Phase 3 is the federal contract that actually pays the bills. Companies that understand the full arc, and design Phase 1 backwards from a Phase 3 customer, convert at far higher rates than companies that pursue each phase as a standalone grant.

For more on the program structure, the 11 funding agencies, and Phase III sole-source authority, see our pillar on what SBIR is. For the eligibility checklist (which applies identically across phases), see our SBIR eligibility requirements guide. And if you are weighing SBIR against its smaller sibling that requires a research-institution partner, our SBIR vs STTR breakdown covers that comparison in detail.

If your endgame is federal revenue, SBIR's three-phase ladder is one of the cleanest entry paths available, see our broader guides on the easiest government contracts to win and government contracting for small business for how SBIR fits into the bigger picture.